Astrid Meyer-Knutsen
@astridmeyerknutsen.bsky.social
Interests: ME/CFS, Long Covid, politics, science, nature and animals. Norwegian but post mostly in English. Newbie allotment gardener.
- Patients often face stigma and psychologization from medical professionals when disease biomarkers are not readily apparent, exemplified by the historic dismissal of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
7/7
7/7
December 4, 2025 at 4:51 PM
- Patients often face stigma and psychologization from medical professionals when disease biomarkers are not readily apparent, exemplified by the historic dismissal of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
7/7
7/7
- Despite being well described in the literature, PAIS remain understudied relative to their high disease burden.
6/7
6/7
December 4, 2025 at 4:51 PM
- Despite being well described in the literature, PAIS remain understudied relative to their high disease burden.
6/7
6/7
- While each PAIS has a unique trigger and pathology, similarities in symptom profiles and immunological findings suggest these conditions may share features or involve overlapping biological mechanisms.
5/7
5/7
December 4, 2025 at 4:51 PM
- While each PAIS has a unique trigger and pathology, similarities in symptom profiles and immunological findings suggest these conditions may share features or involve overlapping biological mechanisms.
5/7
5/7
- A wide variety of pathogens are associated with PAIS, including divergent classes of viruses, bacteria, and parasites.
4/7
4/7
December 4, 2025 at 4:51 PM
- A wide variety of pathogens are associated with PAIS, including divergent classes of viruses, bacteria, and parasites.
4/7
4/7
- While long COVID is a relatively new clinical entity, post-acute infection syndromes (PAIS) have been well documented for over a century.
3/7
3/7
December 4, 2025 at 4:51 PM
- While long COVID is a relatively new clinical entity, post-acute infection syndromes (PAIS) have been well documented for over a century.
3/7
3/7
Highlights
- New or persistent symptoms following COVID-19, known as ‘long COVID’, occur in an estimated 4–20% of pediatric and 10–20% of adult patients after acute infection with SARS-CoV-2. Long COVID is associated with dysregulation of both innate and adaptive immunity.
2/7
- New or persistent symptoms following COVID-19, known as ‘long COVID’, occur in an estimated 4–20% of pediatric and 10–20% of adult patients after acute infection with SARS-CoV-2. Long COVID is associated with dysregulation of both innate and adaptive immunity.
2/7
December 4, 2025 at 4:51 PM
Highlights
- New or persistent symptoms following COVID-19, known as ‘long COVID’, occur in an estimated 4–20% of pediatric and 10–20% of adult patients after acute infection with SARS-CoV-2. Long COVID is associated with dysregulation of both innate and adaptive immunity.
2/7
- New or persistent symptoms following COVID-19, known as ‘long COVID’, occur in an estimated 4–20% of pediatric and 10–20% of adult patients after acute infection with SARS-CoV-2. Long COVID is associated with dysregulation of both innate and adaptive immunity.
2/7
Screenshot from page 15 in the strategic plan:
5/5
5/5
December 4, 2025 at 3:47 PM
Screenshot from page 15 in the strategic plan:
5/5
5/5
- Several regions have recently reported increases in SARS-CoV-2 activity, and uncertainties persist around virus evolution and long-term impacts of COVID-19.
4/5
4/5
December 4, 2025 at 3:47 PM
- Several regions have recently reported increases in SARS-CoV-2 activity, and uncertainties persist around virus evolution and long-term impacts of COVID-19.
4/5
4/5
- Around 6% of those infected develop Post COVID-19 Condition (also known as long COVID), with 15% of these people experiencing symptoms beyond a year.
3/5
3/5
December 4, 2025 at 3:47 PM
- Around 6% of those infected develop Post COVID-19 Condition (also known as long COVID), with 15% of these people experiencing symptoms beyond a year.
3/5
3/5
- Although the global impact of COVID-19 has reduced since the peak of the pandemic, the virus continues to circulate widely, causing severe disease and death in high-risk groups.
2/5
2/5
December 4, 2025 at 3:47 PM
- Although the global impact of COVID-19 has reduced since the peak of the pandemic, the virus continues to circulate widely, causing severe disease and death in high-risk groups.
2/5
2/5
Around 6% of those infected develop Post COVID-19 Condition (also known as long COVID), with 15% of these people experiencing symptoms beyond a year.
3/5
3/5
December 4, 2025 at 3:38 PM
Around 6% of those infected develop Post COVID-19 Condition (also known as long COVID), with 15% of these people experiencing symptoms beyond a year.
3/5
3/5
Although the global impact of COVID-19 has reduced since the peak of the pandemic, the virus continues to circulate widely, causing severe disease and death in high-risk groups.
2/5
2/5
December 4, 2025 at 3:38 PM
Although the global impact of COVID-19 has reduced since the peak of the pandemic, the virus continues to circulate widely, causing severe disease and death in high-risk groups.
2/5
2/5
... and this is why I avoid going to the doctor. It's unfathomable to me that we still don't have any measures in place in healthcare to avoid transmission of such a dangerous infection as Covid-19.
December 4, 2025 at 11:34 AM
... and this is why I avoid going to the doctor. It's unfathomable to me that we still don't have any measures in place in healthcare to avoid transmission of such a dangerous infection as Covid-19.